Early Clopidogrel Versus Prasugrel Use Among Contemporary STEMI and NSTEMI Patients in the US: Insights From the National Cardiovascular Data Registry

por Sherwood, Matthew W., Wiviott, Stephen D., Peng, S. Andrew, Roe, Matthew T., DeLemos, James, Peterson, Eric D., Wang, Tracy Y.
Publicado 2014

Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial

por Murphy, Sabina A., Antman, Elliott M., Wiviott, Stephen D., Weerakkody, Govinda, Morocutti, Giorgio, Huber, Kurt, Lopez-Sendon, Jose, McCabe, Carolyn H., Braunwald, Eugene
Publicado 2008

Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long‐Term Follow‐Up After Acute Coronary Syndromes

por Fanaroff, Alexander C., Roe, Matthew T., Clare, Robert M., Lokhnygina, Yuliya, Navar, Ann Marie, Giugliano, Robert P., Wiviott, Stephen D., Tershakovec, Andrew M., Braunwald, Eugene, Blazing, Michael A.
Publicado 2017

Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF‐TIMI 48 Trial

por Eisen, Alon, Ruff, Christian T., Braunwald, Eugene, Nordio, Francesco, Corbalán, Ramón, Dalby, Anthony, Dorobantu, Maria, Mercuri, Michele, Lanz, Hans, Rutman, Howard, Wiviott, Stephen D., Antman, Elliott M., Giugliano, Robert P.
Publicado 2016

Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-IT

por Giugliano, Robert P., Gencer, Baris, Wiviott, Stephen D., Park, Jeong-Gun, Fuchs, Charles S., Goessling, Wolfram, Musliner, Thomas A., Tershakovec, Andrew M., Blazing, Michael A., Califf, Robert, Cannon, Christopher P., Braunwald, Eugene
Publicado 2020

Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes

por Moura, Filipe A., Berg, David D., Bellavia, Andrea, Dwyer, Jamie P., Mosenzon, Ofri, Scirica, Benjamin M., Wiviott, Stephen D., Bhatt, Deepak L., Raz, Itamar, Feinberg, Mark W., Braunwald, Eugene, Morrow, David A., Sabatine, Marc S.
Publicado 2023

Association of Hospital-Level Differences in Care With Outcomes Among Patients With Acute ST-Segment Elevation Myocardial Infarction in China

por Xu, Haiyan, Yang, Yuejin, Wang, Chuangshi, Yang, Jingang, Li, Wei, Zhang, Xuan, Ye, Yunqing, Dong, Qiuting, Fu, Rui, Sun, Hui, Yan, Xinxin, Gao, Xiaojin, Wang, Yang, Jia, Xuan, Sun, Yi, Wu, Yuan, Zhang, Jun, Zhao, Wei, Sabatine, Marc S., Wiviott, Stephen D.
Publicado 2020

A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes

por Berg, David D., Wiviott, Stephen D., Scirica, Benjamin M., Zelniker, Thomas A., Goodrich, Erica L., Jarolim, Petr, Mosenzon, Ofri, Cahn, Avivit, Bhatt, Deepak L., Leiter, Lawrence A., McGuire, Darren K., Wilding, John P.H., Johanson, Per, Langkilde, Anna Maria, Raz, Itamar, Braunwald, Eugene, Sabatine, Marc S., Morrow, David A.
Publicado 2021

Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis

por Kato, Eri Toda, Morrow, David A, Guo, Jianping, Berg, David D, Blazing, Michael A, Bohula, Erin A, Bonaca, Marc P, Cannon, Christopher P, de Lemos, James A, Giugliano, Robert P, Jarolim, Petr, Kempf, Tibor, Kristin Newby, L, O’Donoghue, Michelle L, Pfeffer, Marc A, Rifai, Nader, Wiviott, Stephen D, Wollert, Kai C, Braunwald, Eugene, Sabatine, Marc S
Publicado 2022

Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54

por Bonaca, Marc P., Wiviott, Stephen D., Morrow, David A., Steg, P. Gabriel, Hamm, Christian, Bhatt, Deepak L., Storey, Robert F., Cohen, Marc, Kuder, Julia, Im, KyungAh, Magnani, Giulia, Budaj, Andrzej, Nicolau, José C., Parkhomenko, Alexander, López‐Sendón, José, Dellborg, Mikael, Diaz, Rafael, Van de Werf, Frans, Corbalán, Ramón, Goudev, Assen, Jensen, Eva C., Johanson, Per, Braunwald, Eugene, Sabatine, Marc S.
Publicado 2018

The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58

por Mosenzon, Ofri, Wiviott, Stephen D., Heerspink, Hiddo J.L., Dwyer, Jamie P., Cahn, Avivit, Goodrich, Erica L., Rozenberg, Aliza, Schechter, Meir, Yanuv, Ilan, Murphy, Sabina A., Zelniker, Thomas A., Gause-Nilsson, Ingrid A.M., Langkilde, Anna Maria, Fredriksson, Martin, Johansson, Peter A., Bhatt, Deepak L., Leiter, Lawrence A., McGuire, Darren K., Wilding, John P.H., Sabatine, Marc S., Raz, Itamar
Publicado 2021

Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial

por Mosenzon, Ofri, Raz, Itamar, Wiviott, Stephen D., Schechter, Meir, Goodrich, Erica L., Yanuv, Ilan, Rozenberg, Aliza, Murphy, Sabina A., Zelniker, Thomas A., Langkilde, Anna Maria, Gause-Nilsson, Ingrid A.M., Fredriksson, Martin, Johansson, Peter A., Wilding, John P.H., McGuire, Darren K., Bhatt, Deepak L., Leiter, Lawrence A., Cahn, Avivit, Dwyer, Jamie P., Heerspink, Hiddo J.L., Sabatine, Marc S.
Publicado 2022